T834-1237 Screening compound: methyl 1-[5-(2-methylpropyl)-4-oxo-4H,5H-pyrazolo[1,5-a]quinoxaline-2-carbonyl]pyrrolidine-2-carboxylate

T834-1237 Screening compound: methyl 1-[5-(2-methylpropyl)-4-oxo-4H,5H-pyrazolo[1,5-a]quinoxaline-2-carbonyl]pyrrolidine-2-carboxylate
T834-1237 Screening compound: methyl 1-[5-(2-methylpropyl)-4-oxo-4H,5H-pyrazolo[1,5-a]quinoxaline-2-carbonyl]pyrrolidine-2-carboxylate alternative view

Chemical Structure Depiction of ChemDiv screening compound T834-1237
methyl 1-[5-(2-methylpropyl)-4-oxo-4H,5H-pyrazolo[1,5-a]quinoxaline-2-carbonyl]pyrrolidine-2-carboxylate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T834-1237

Molecular Formula

C21H24N4O4 (C21 H24 N4 O4)

Compound Name

methyl 1-[5-(2-methylpropyl)-4-oxo-4H,5H-pyrazolo[1,5-a]quinoxaline-2-carbonyl]pyrrolidine-2-carboxylate

IUPAC name

methyl 1-[5-(2-methylpropyl)-4-oxo-4H5H-pyrazolo[15-a]quinoxaline-2-carbonyl]pyrrolidine-2-carboxylate

SMILES

CC(C)CN(c(cccc1)c1-n(c1c2)nc2C(N(CCC2)C2C(OC)=O)=O)C1=O

InChI

InChI=1S/C21H24N4O4/c1-13(2)12-24-15-7-4-5-8-16(15)25-18(20(24)27)11-14(22-25)19(26)23-10-6-9-17(23)21(28)29-3/h4-5,7-8,11,13,17H,6,9-10,12H2,1-3H3/t17-/m0/s1

InChI Key

KGUYSWPAHKNXAN-KRWDZBQOSA-N

MDL Number (MFCD)

MFCD29029321

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

396.45

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.445

Distribution Coefficient, logD

2.445

Water Solubility, LogSw

-2.59

Polar Surface Area

65.858

Acid Dissociation Constant (pKa)

18.98

Base Dissociation Constant (pKb)

-4.95

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

42.90

T834-1237 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

Antiviral Library (67538 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Hemic and lymphatic
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with T834-1237 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T834-1237?
Check Price and Availability of T834-1237, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T834-1237 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T834-1237
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T834-1237
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T834-1237 available by request